Global Human Microbiome Market worth USD 1.99 Billion by 2024

Global Human Microbiome Market worth USD 1.99 Billion by 2024

Pune, India, April 03, 2019 -- /360iResearch/ -- The report "Global Human Microbiome Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q1 2019 Update)", published by 360iResearch, states that the global market was valued at USD 0.49 billion in 2017 and is projected to reach USD 1.99 billion by 2024, growing at a CAGR of 22.16% from 2017 to 2024.

The major forces driving the growth of the human microbiome market include the increased focus on human microbiome therapy and human microbiome for drug development, early disease detection, and diagnosis. However certain factors such as the limited expertise and lack of comprehensive research may hinder the market growth. In the middle of difficulty lies opportunity such as the increasing collaborations and research investments to create growth opportunities, and development of human microbiome therapeutic products. The possible challenges for the market growth is causal links between microbiota dysbiosis and disease. But key players in the market are overcoming the challenges with continual improvement and innovation.

Based on disease, the global human microbiome market is studied across Acute Diarrhea, Autoimmune Disorders, Cancer, Diabetes, Mental Disorders, and Obesity. Based on product, the global human microbiome market is studied across Diagnostic Devices, Drugs, Foods, Medical Foods, Prebiotics, and Probiotics. Based on technology, the global human microbiome market is studied across 16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, Metagenomic Sequencing, and Omics Technology. Based on theuraptic area, the global human microbiome market is studied across Gastrointestinal Disorders, Metabolic Disorders, Skin Disorders, and Women’s Health. Based on application, the global human microbiome market is studied across Diagnostics, and Therapeutics. Based on geography, the global human microbiome market is studied across Americas, Europe, Middle East & Africa, and Asia-Pacific.

The report features a competitive scenario of the human microbiome market and provides inclusive analysis of key growth strategies adopted by major players. Key company profiled in the study are DuPont, E.I. Du Pont De Nemours and Company, Enterome Bioscience, Merck & Co., Inc., Metabiomics Corporation, Microbiome Therapeutics, LLC, Osel, Inc., Second Genome, Inc., Seres Therapeutics, Synthetic Biologics Inc., Vedanta Biosciences, Inc., Vithera Pharmaceuticals, and Yakult Honsha Co., Ltd..

About 360iResearch

360iResearch LLP, headquartered in Pune, India, is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as Aerospace & Defense, Agriculture, Automotive & Transportation, Building, Construction & Real Estate, Chemicals & Advanced Material, Consumer Goods & Retail, Energy & Utilities, Food & Beverage, Healthcare & Life Sciences, Information Technology, Packaging, and Semiconductor & Electronics.

Miss. Shikha Sachan
Business Lead,
Nyati Elan,
Wagholi, Pune,
India - 412207.
USA: +1-530-264-8485
India: +91-9075017818
Email: [email protected]